Kardi Ai
- Company typePrivate
- Founded2021
- HeadquartersOlomouc, Czechia
- Headcount1–10
- GTM typeB2B and B2C
- OfferingSoftware
Kardi Ai firmographics
Firmographics- Name
- Kardi Ai
- Legal name
- KARDI AI Technologies s.r.o.
- Website
- https://kardi.ai
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Kardi Ai industry classification
Industry- Product category
- Cardiac Monitoring Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders) (HLAHACAB)
- akta.pro secondary industries
- ECG/EKG & Heart Rhythm Monitors (Consumer) (CRACAQAC), Cardiology Telemedicine Platforms (HLALAGAB), Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA)
Keywords
Where Kardi Ai is headquartered
LocationHeadquarters
- HQ city
- Olomouc
- HQ country
- Czechia
- HQ region
- Europe
Offices1 record
Markets served
Kardi Ai business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure, Supply Chain
Revenue model
- Hardware + Software Subscription Bundle: Kardi AI operates on a subscription model bundled with hardware (chest strap device). The device is provided as part of the first subscription and becomes user property after purchase. Subscriptions are offered in various periods (monthly, annual, or multi-year) with the option to pay in monthly installments. The subscription includes device usage, cloud data storage, AI analysis, and access to the mobile application.
- Insurance Reimbursement: The service is reimbursable by Czech health insurance companies, providing an additional revenue pathway and reducing consumer cost barriers. This reimbursement model supports adoption among Czech patients.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Annual subscription with upfront payment |
| Subscription | Monthly | Annual subscription with monthly installments |
| Subscription | Monthly | Monthly subscription |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels8 records
Kardi Ai product offering
Product offeringCore offering
Kardi Ai provides an AI-powered long-term ECG monitoring medical device (EU MDR Class IIa certified) consisting of a wearable chest strap sensor paired with a certified mobile application. The system performs automated single-lead ECG recording and analysis, detecting seven heart rhythm disorders and delivering AI-evaluated results to users within 5 minutes while generating detailed PDF reports for cardiologists.
Product overview
Kardi Ai is a preventive heart monitoring medtech solution comprising three integrated components: (1) a certified Class IIa medical device combining a hardware chest strap with an AI-powered mobile app for long-term ECG monitoring; (2) cloud-based AI analysis that evaluates heart rhythm data and detects 7 cardiac disorders; and (3) Beatwell, a companion wellness app for everyday heart rhythm tracking. The product enables users to measure ECG anytime, anywhere, with AI-generated results delivered within 5 minutes and detailed PDF reports shared with cardiologists.
Differentiator
Problem solved
Functional benefit
Brands
- Beatwell: A wellness-focused heart rhythm overview solution providing simple feedback through a color-coded scale. It is not a medical device but an accessible solution for everyday monitoring and supporting an active lifestyle.
Products and services
- Kardi Ai AI-powered long-term ECG monitoring medical device (EU MDR Class IIa certified) combining a chest strap sensor with a mobile application for iOS and Android. Detects 7 heart rhythm disorders including atrial fibrillation using certified AI, delivers results within 5 minutes, and generates detailed PDF reports for physicians. Includes 78 days of measurement capability.
- Beatwell
Quantifiable outcome
- 29% of users discovered arrhythmia through Kardi Ai monitoring
- +4 more outcomes
Companies that use Kardi Ai
Customer profileNamed customers7 records
Segments3 records
Ideal customer profiles2 records
Kardi Ai technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature5 records
Kardi Ai partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and support.
- MedicovercoreMedicover signed expansion partnership agreement with Kardi AI for providing cardiac monitoring services in target European markets including Bulgaria, Poland, and Slovakia.
- HaelancoreHaelan partnered with Kardi AI for cardiac monitoring service expansion across CEE markets as part of the company's multi-country market entry strategy.
- AcibademcoreAcibadem, international healthcare provider, signed partnership with Kardi AI for cardiac monitoring services deployment in target markets.
- HITLABcoreKardi AI is pursuing FDA pathway in cooperation with HITLAB, a healthcare innovation research organization, to support US market entry regulatory requirements.
- CzechInvestsupportCzechInvest supports Kardi AI through national programs for innovation development, technology advancement, and international expansion, including NPO certification and internationalization programs.
- European UnionsupportKardi AI received EU funding support through European Regional Development Fund and national operational programs for digital economy and innovative startups.
Scale indicators9 records
Recent moves8 records
Expansion highlights6 records
Kardi Ai competitors and assessment
Company assessmentBroad incumbents
- Boston Scientific: Boston Scientific acquired Preventice Solutions, a provider of ambulatory ECG monitors (BodyGuardian), giving it a foothold in the same long-term cardiac monitoring market Kardi Ai targets. Serves the same cardiology/hospital channel but as part of a much broader device portfolio.
- Philips (BioTelemetry / Cardiac Care): Philips, through BioTelemetry, is a leading provider of remote cardiac monitoring services (MCOT, Holter) with established hospital channels and payor relationships globally. Overlaps with Kardi Ai in long-term ambulatory ECG monitoring but operates at much larger scale across multiple monitoring modalities.
- GE Healthcare (MUSE / ECG): GE Healthcare is a global incumbent in cardiology diagnostics, with MUSE cardiology information systems, resting ECG, and Holter products sold to hospitals and clinics. While not directly competing in the consumer single-lead segment, it competes in the same downstream cardiology workflow that Kardi Ai's physician portal feeds into.
- Baxter (Bardy Diagnostics / Hillrom): Baxter (via Hillrom/BardyDx) offers the Carnation Ambulatory Monitor, a patch-based long-term ECG monitor with AI analysis. Comparable to Kardi Ai in long-duration single-lead ambulatory ECG and AI arrhythmia detection, but distributed through Baxter's large hospital sales infrastructure.
Emerging players
- Qardio: Qardio produces consumer ECG and remote patient monitoring devices (QardioCore chest strap, QardioArm blood pressure). Comparable to Kardi Ai in the consumer-facing wearable ECG and remote cardiac monitoring category, though positioned more as a wellness/RPM platform than a certified diagnostic.
- Withings: Withings produces consumer health devices including Move ECG (single-lead ECG watch/scale) with a companion app that detects AF. Comparable to Kardi Ai in consumer ECG hardware and app-driven arrhythmia screening, though positioned more as a wellness device than a certified diagnostic.
- Eko Health: Eko Health makes AI-enabled digital stethoscopes with ECG and cardiac abnormality detection algorithms (FDA-cleared). Comparable to Kardi Ai in AI-driven cardiac signal analysis, though delivered through a clinician-facing stethoscope form factor rather than a consumer wearable.
Direct peers
- AliveCor: AliveCor's KardiaMobile is a consumer/single-lead ECG device paired with an AI-driven arrhythmia detection app, FDA-cleared and widely prescribed. It is the closest direct peer to Kardi Ai in terms of single-lead ECG hardware, mobile app, AI arrhythmia detection, and consumer-plus-clinician distribution model.
- iRhythm Technologies: iRhythm's Zio long-term continuous ECG patch (up to 14 days) is a prescription-based cardiac monitor with AI-assisted analysis. Direct peer in long-duration ambulatory ECG monitoring for arrhythmia detection, addressing the same Holter-replacement use case that Kardi Ai targets.
- Coala Life: Coala Life is a Swedish ECG remote monitoring company with a chest-mounted device and cloud-based AI analysis for arrhythmia detection. Highly comparable to Kardi Ai in product form factor (chest ECG), AI-based analysis, and Nordic/CE-certification-led GTM.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights8 records
Customer concentration
Kardi Ai social profiles
Digital presenceKardi Ai compliance and trust
Trust signalCompliance2 records
Kardi Ai financial estimates
Financial estimateRevenue estimate
Valuation estimate
Kardi Ai leadership team
Management profileNumber of profiles
Profiles5 records
Kardi Ai funding detail
Funding detailFunding overview
Funding rounds4 records
Investors8 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Kardi Ai M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Kardi Ai
What does Kardi Ai do?
Kardi Ai provides an AI-powered long-term ECG monitoring medical device (EU MDR Class IIa certified) consisting of a wearable chest strap sensor paired with a certified mobile application. The system performs automated single-lead ECG recording and analysis, detecting seven heart rhythm disorders and delivering AI-evaluated results to users within 5 minutes while generating detailed PDF reports for cardiologists.
Is Kardi Ai a public or private company?
Kardi Ai is a private company. It is classified as venture growth investor backed and is currently operating.
When was Kardi Ai founded?
Kardi Ai was founded in 2021. It employs 1 to 10 people.
Where is Kardi Ai based?
Kardi Ai is headquartered in Olomouc, Czechia, in the Europe region.
How does Kardi Ai make money?
Two revenue lines are on record. Hardware + Software Subscription Bundle is the primary driver. The others are insurance Reimbursement.
Who are Kardi Ai's main competitors?
Broad incumbents on record are Boston Scientific, Philips (BioTelemetry / Cardiac Care), GE Healthcare (MUSE / ECG) and Baxter (Bardy Diagnostics / Hillrom). Emerging players are Qardio, Withings and Eko Health. Direct peers are AliveCor, iRhythm Technologies and Coala Life.
Does Kardi Ai have an API?
No public API is recorded for Kardi Ai.
What industry is Kardi Ai in?
Kardi Ai's product category is Cardiac Monitoring Devices. Its primary akta.pro industry code is HLAHACAB, Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders), with a secondary code of CRACAQAC, ECG/EKG & Heart Rhythm Monitors (Consumer). Its NAICS code is 334510 and its SIC code is 3845.